GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,634,000 | -12.0% | 37,482 | -12.0% | 0.07% | +13.1% |
| Q1 2022 | $1,857,000 | +5.8% | 42,617 | +7.1% | 0.06% | +19.6% |
| Q4 2021 | $1,756,000 | +23.0% | 39,801 | +6.6% | 0.05% | +13.3% |
| Q3 2021 | $1,428,000 | -8.7% | 37,347 | -5.0% | 0.04% | -11.8% |
| Q2 2021 | $1,564,000 | -0.9% | 39,307 | -11.1% | 0.05% | -8.9% |
| Q1 2021 | $1,578,000 | +21.5% | 44,191 | +25.3% | 0.06% | -18.8% |
| Q4 2020 | $1,299,000 | -53.4% | 35,259 | -51.4% | 0.07% | -53.7% |
| Q3 2020 | $2,788,000 | +32.0% | 72,491 | +40.1% | 0.15% | +5.7% |
| Q2 2020 | $2,112,000 | +5.1% | 51,738 | -2.3% | 0.14% | -17.5% |
| Q1 2020 | $2,009,000 | +60.3% | 52,966 | +98.9% | 0.17% | +59.8% |
| Q4 2019 | $1,253,000 | -10.3% | 26,630 | -18.6% | 0.11% | -22.5% |
| Q3 2019 | $1,397,000 | +7.3% | 32,711 | +0.7% | 0.14% | -3.5% |
| Q2 2019 | $1,302,000 | +3.1% | 32,498 | +7.6% | 0.14% | -9.5% |
| Q1 2019 | $1,263,000 | +12.6% | 30,198 | +2.9% | 0.16% | -1.2% |
| Q4 2018 | $1,122,000 | -8.2% | 29,352 | -3.5% | 0.16% | +10.3% |
| Q3 2018 | $1,222,000 | -5.3% | 30,407 | -4.9% | 0.14% | -14.7% |
| Q2 2018 | $1,290,000 | +3.0% | 31,971 | -0.2% | 0.17% | -2.9% |
| Q1 2018 | $1,252,000 | -37.3% | 32,022 | -43.1% | 0.18% | -35.2% |
| Q4 2017 | $1,997,000 | -14.8% | 56,298 | +3.6% | 0.27% | -36.5% |
| Q2 2017 | $2,345,000 | +1.6% | 54,365 | -0.6% | 0.42% | -7.6% |
| Q1 2017 | $2,308,000 | +13.6% | 54,712 | +3.7% | 0.46% | +11.4% |
| Q4 2016 | $2,032,000 | +46.8% | 52,764 | -5.4% | 0.41% | +52.4% |
| Q3 2016 | $1,384,000 | -2.7% | 55,755 | -2.8% | 0.27% | -4.9% |
| Q2 2016 | $1,423,000 | +30.4% | 57,354 | +112.2% | 0.28% | +29.0% |
| Q4 2015 | $1,091,000 | -18.2% | 27,027 | -22.0% | 0.22% | -30.9% |
| Q3 2015 | $1,333,000 | +6.5% | 34,649 | +15.4% | 0.32% | +2.9% |
| Q2 2015 | $1,252,000 | -13.6% | 30,030 | -4.4% | 0.31% | -11.9% |
| Q1 2015 | $1,449,000 | -88.5% | 31,409 | -39.4% | 0.35% | +31.2% |
| Q4 2014 | $12,593,000 | +1274.8% | 51,841 | +160.3% | 0.27% | +93.5% |
| Q3 2014 | $916,000 | -99.9% | 19,917 | -18.2% | 0.14% | -10.9% |
| Q2 2014 | $663,906,000 | +165462.6% | 24,362 | +224.4% | 0.16% | +28.9% |
| Q1 2014 | $401,000 | +18.3% | 7,509 | +18.4% | 0.12% | +12.0% |
| Q4 2013 | $339,000 | +3.0% | 6,341 | -3.4% | 0.11% | -3.6% |
| Q3 2013 | $329,000 | +16.3% | 6,565 | +15.7% | 0.11% | +16.7% |
| Q2 2013 | $283,000 | – | 5,673 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |